As of November 10, 2026, 6 holders' latest Schedule 13D or 13G filings report owning 5% or more of Eyepoint, Inc. The largest reported stake is JANUS HENDERSON GROUP Ltd.'s, at 10.9%. 21 filings are on record since July 8, 2025 (Schedule 13G, September 8, 2026).
Sell to companies like Eyepoint, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Federated Hermes, Inc. · Sole voting: 1,367,142 · Shared voting: 0 · Sole dispositive: 1,367,142 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-11-04
- · Reporting person: Vanguard Capital Management · Sole voting: 637,314 · Shared voting: 0 · Sole dispositive: 4,305,688 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-10-30
- · Reporting person: Tang Capital Management, LLC · Sole voting: 0 · Shared voting: 8,250,200 · Sole dispositive: 0 · Shared dispositive: 8,250,200 · SCHEDULE 13G, 2026-10-27
- · Holder: Federated Hermes, Inc. · Percent: 8.04% · SCHEDULE 13G/A
- · Reporting person: JANUS HENDERSON GROUP Ltd. · Sole voting: 0 · Shared voting: 9,366,332 · Sole dispositive: 0 · Shared dispositive: 9,366,332 · SCHEDULE 13G, 2026-09-08
Eyepoint, Inc. has 21 Schedule 13D or 13G filings on record since 2025-07-08. 6 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Layoffs on record: 1 filing or notice, latest 2026-10-19 (layoff filings and notices).
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| JANUS HENDERSON GROUP Ltd. | 10.9% | 9,366,332 | SCHEDULE 13G, 2026-09-08 | 2026-08-31 |
| Tang Capital Management, LLC | 9.6% | 8,250,200 | SCHEDULE 13G, 2026-10-27 | 2026-10-20 |
| Cormorant Asset Management, LP | 8.35% | 7,000,000 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| BlackRock, Inc. | 7.7% | 6,430,477 | SCHEDULE 13G/A, 2026-07-28 | 2026-06-30 |
| Adage Capital Management, L.P. | 5.71% | 4,790,792 | SCHEDULE 13G, 2026-08-12 | 2026-06-30 |
| Commodore Capital LP | 5.1% | 4,250,000 | SCHEDULE 13G, 2026-06-03 | 2026-05-27 |
| Vanguard Capital Management | 4.99% | 4,305,688 | SCHEDULE 13G/A, 2026-10-30 | 2026-09-30 |
| TCG Crossover GP II, LLC | 4.3% | 3,572,335 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| Paradigm BioCapital Advisors LP | 3.8% | 3,142,437 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Federated Hermes, Inc. | 1.59% | 1,367,142 | SCHEDULE 13G/A, 2026-11-04 | 2026-10-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Holding shares or following this stake? See who's behind Eyepoint, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Eyepoint, Inc. and the records around it.
Eyepoint, Inc. elsewhere on the record
Companies that share a holder
- Federated Hermes, Inc. also filed stake reports on 13 other companies: Arcturus Therapeutics Holdings Inc. (Oct 2026), Forte Biosciences, Inc. (Sep 2026), SCYNEXIS INC (Jul 2026)
- Cormorant Asset Management, LP also filed stake reports on 17 other companies: Corbus Pharmaceuticals Holdings, Inc. (Nov 2026), Adlai Nortye Ltd. (Aug 2026), BioAge Labs, Inc. (Aug 2026)
- TCG Crossover GP II, LLC also filed stake reports on 21 other companies: ALX Oncology Holdings Inc. (Aug 2026), First Tracks Biotherapeutics, Inc. (Aug 2026), Fulcrum Therapeutics, Inc. (Aug 2026)
Watch Eyepoint, Inc.
Get an email when Eyepoint, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Eyepoint, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Eyepoint, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Eyepoint, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
22 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP Ltd. | 0 | 9,366,332 | 0 | 9,366,332 | SCHEDULE 13G, 2026-09-08 |
| Tang Capital Management, LLC | 0 | 8,250,200 | 0 | 8,250,200 | SCHEDULE 13G, 2026-10-27 |
| Kevin Tang | 0 | 8,250,200 | 0 | 8,250,200 | SCHEDULE 13G, 2026-10-27 |
| Tang Capital Partners, LP | 0 | 1,781,303 | 0 | 1,781,303 | SCHEDULE 13G, 2026-10-27 |
| Tang Capital Partners International, LP | 0 | 2,664,481 | 0 | 2,664,481 | SCHEDULE 13G, 2026-10-27 |
| Tang Capital Partners Iii, Inc | 0 | 1,894,208 | 0 | 1,894,208 | SCHEDULE 13G, 2026-10-27 |
| Tang Capital Partners Iv, Inc | 0 | 1,910,208 | 0 | 1,910,208 | SCHEDULE 13G, 2026-10-27 |
| Cormorant Asset Management, LP | 0 | 7,000,000 | 0 | 7,000,000 | SCHEDULE 13G/A, 2026-08-14 |
| Bihua Chen | 0 | 7,000,000 | 0 | 7,000,000 | SCHEDULE 13G/A, 2026-08-14 |
| BlackRock, Inc. | 6,290,331 | 0 | 6,430,477 | 0 | SCHEDULE 13G/A, 2026-07-28 |
| Adage Capital Management, L.P. | 0 | 4,790,792 | 0 | 4,790,792 | SCHEDULE 13G, 2026-08-12 |
| Robert Atchinson | 0 | 4,790,792 | 0 | 4,790,792 | SCHEDULE 13G, 2026-08-12 |
| Phillip Gross | 0 | 4,790,792 | 0 | 4,790,792 | SCHEDULE 13G, 2026-08-12 |
| Commodore Capital LP | 0 | 4,250,000 | 0 | 4,250,000 | SCHEDULE 13G, 2026-06-03 |
| Commodore Capital Master LP | 0 | 4,250,000 | 0 | 4,250,000 | SCHEDULE 13G, 2026-06-03 |
| Robert Egen Atkinson | 0 | 4,250,000 | 0 | 4,250,000 | SCHEDULE 13G, 2026-06-03 |
| Michael Kramarz | 0 | 4,250,000 | 0 | 4,250,000 | SCHEDULE 13G, 2026-06-03 |
| Vanguard Capital Management | 637,314 | 0 | 4,305,688 | 0 | SCHEDULE 13G/A, 2026-10-30 |
| Federated Hermes, Inc. | 1,367,142 | 0 | 1,367,142 | 0 | SCHEDULE 13G/A, 2026-11-04 |
| Voting Shares Irrevocable Trust | 1,367,142 | 0 | 1,367,142 | 0 | SCHEDULE 13G/A, 2026-11-04 |
| Thomas R. Donahue | 0 | 1,367,142 | 0 | 1,367,142 | SCHEDULE 13G/A, 2026-11-04 |
| Ann C. Donahue | 0 | 1,367,142 | 0 | 1,367,142 | SCHEDULE 13G/A, 2026-11-04 |
| J. Christopher Donahue | 0 | 1,367,142 | 0 | 1,367,142 | SCHEDULE 13G/A, 2026-11-04 |
The latest filing identifies Eyepoint, Inc. by CUSIP 30233G209 and gives its principal executive office as 480 Pleasant Street, Suite C400, Watertown, MA 02472 (SCHEDULE 13G/A, 2026-11-04).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-08 | Federated Hermes, Inc. | 6.68% | SCHEDULE 13G/A |
| 2025-08-12 | Adage Capital Management, L.P. | 9.88% | SCHEDULE 13G/A |
| 2025-10-17 | BlackRock, Inc. | 6.5% | SCHEDULE 13G/A |
| 2025-11-13 | Adage Capital Management, L.P. | 8.07% | SCHEDULE 13G/A |
| 2025-12-08 | Cormorant Asset Management, LP | 9.98% | SCHEDULE 13G/A |
| 2026-02-12 | Adage Capital Management, L.P. | 5.68% | SCHEDULE 13G/A |
| 2026-02-17 | TCG Crossover GP II, LLC | 4.3% | SCHEDULE 13G/A |
| 2026-02-24 | Paradigm BioCapital Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-13 | Adage Capital Management, L.P. | 3.96% | SCHEDULE 13G/A |
| 2026-05-15 | Paradigm BioCapital Advisors LP | 3.8% | SCHEDULE 13G/A |
| 2026-06-03 | Commodore Capital LP | 5.1% | SCHEDULE 13G |
| 2026-07-28 | BlackRock, Inc. | 7.7% | SCHEDULE 13G/A |
| 2026-07-31 | Vanguard Capital Management | 5.03% | SCHEDULE 13G |
| 2026-08-12 | Adage Capital Management, L.P. | 5.71% | SCHEDULE 13G |
| 2026-08-14 | Cormorant Asset Management, LP | 8.35% | SCHEDULE 13G/A |
| 2026-09-08 | JANUS HENDERSON GROUP Ltd. | 10.9% | SCHEDULE 13G |
| 2026-10-07 | Federated Hermes, Inc. | 8.04% | SCHEDULE 13G/A |
| 2026-10-27 | Tang Capital Management, LLC | 9.6% | SCHEDULE 13G |
| 2026-10-30 | Vanguard Capital Management | 4.99% | SCHEDULE 13G/A |
| 2026-11-04 | Federated Hermes, Inc. | 1.59% | SCHEDULE 13G/A |
Questions about who owns Eyepoint, Inc.
Who owns Eyepoint, Inc.?
On this page, 6 holders' latest ownership filings report 5% or more of Eyepoint, Inc.: JANUS HENDERSON GROUP Ltd. (10.9%, Schedule 13G, filed 2026-09-08), Tang Capital Management, LLC (9.6%, Schedule 13G, filed 2026-10-27), Cormorant Asset Management, LP (8.35%, Schedule 13G/A, filed 2026-08-14), BlackRock, Inc. (7.7%, Schedule 13G/A, filed 2026-07-28) and Adage Capital Management, L.P. (5.71%, Schedule 13G, filed 2026-08-12); 1 more is listed above.
Who are the largest shareholders of Eyepoint, Inc.?
By the share each holder's latest filing reports, the largest holders of Eyepoint, Inc. on this page are JANUS HENDERSON GROUP Ltd. (10.9%), Tang Capital Management, LLC (9.6%) and Cormorant Asset Management, LP (8.35%).
When did JANUS HENDERSON GROUP Ltd. buy into Eyepoint, Inc.?
The filings give report dates, not purchase dates. The earliest filing from JANUS HENDERSON GROUP Ltd. on this page is the Schedule 13G, filed 2026-09-08, reporting 10.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 21 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Eyepoint, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.